Influence of growth hormone on accretion of bone mass

Hormone Research

Volumn 58, Issue SUPPL. 1, 2002, Pages 52-56

  Monson, J P ^a   Drake, W M ^a   Carroll, P V ^a   Weaver, J U ^a   Rodriguez Arnao, J ^a   Savage, M O ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Bone accretion; Bone mineral density

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; STEROID; THYROXINE;

AGING; BODY HEIGHT; BONE DENSITY; BONE GROWTH; BONE MASS; BONE METABOLISM; BONE REMODELING; CONFERENCE PAPER; FRACTURE; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; ONSET AGE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0036419175     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064765     Document Type: Conference Paper

References (21)

1. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M: Bone mineral status in growth hormone deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 1992;74:118-123.
2. De Boer H, Blok GJ, Van Lingen A, Teule GJJ, Lips P, Van der Veen EA: Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res 1994;9:1319-1326.
3. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S: The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 1996;81:3077-3083.
4. Degerblad M, Bengtsson BÅ, Bramnert M, Johnell O, Manhem P, Rosén T, Thorén M: Reduced bone mineral density in adults with growth hormone (GH) deficiency: Increased bone turnover during 12 months of GH substitution therapy. Eur J Endocrinol 1995;133:180-188.
5. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM: Reduced bone mineral density in patients with adult-onset growth hormone deficiency. J Clin Endocrinol Metab 1994;78:669-674.
6. Johannsson G, Rosén T, Bosaeus I, Sjostrom L, Bengtsson, BÅ: Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 1996;81:2865-2873.
7. Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J: Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin Endocrinol 1998;48:561-568.
8. Drake WM, Rodriguez-Arnao J, Weaver JU, James I, Coyte D, Spector T, Besser GM, Monson JP: The influence of gender on the short- and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults - A five-year study. Clin Endocrinol 2001;54:525-532.
9. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE Shalet SM: Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 1993;76:1344-1348.
10. Zamboni G, Antoniazzi F, Radetti G, Musumeci C, Tatò L: Effect of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. J Pediatr 1991;119:483-485.
11. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G: Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 1993;122:37-45.
12. Degerblad M, Elgindy N, Hall K, Sjoberg HE, Thoren M: Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol Copenh 1992;126:387-393.
13. Vandeweghe M, Taelman P, Kaufman JM: Short- and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 1993;39:409-415.
14. Bonjour JPH, Theintz G, Buchs B, Slosman D, Rizzoli R: Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metabol 1991;73:555-563.
15. Wüster C, Slencza E, Zeigler R: Erhöhte prävalenz von osteoporose und arteriosklerose bei konventionell substituierter hypophysen-vorderlappeninsuffizienz: Bedarf einer zusätzlichen wachtumshormonsubstitution? Klin Wochenschr 1991;69:769-773.
16. Rosén T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BÅ: Increased fracture frequency in adult patients with hypopituitarism and growth hormone deficiency. Eur J Endocrinol 1997;137:240-245.
17. Wüster C, Abs R, Bengtsson BÅ, Bennmarker H, Feldt-Rasmussen U, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P: The influence of growth hormone deficiency, growth hormone replacement therapy and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 2001;16:398-405.
18. Carroll PV, Christ ER and Members of the Growth Hormone Research Society Scientific Committee: Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. J Clin Endocrinol Metab 1998;83:382-395.
19. Ohlsson C, Bengtsson BÅ, Isaksson OGP, Andreassen TT, Slootweg MC: Growth hormone and bone. Endocr Rev 1998;19:55-79.
20. Drake WM, Coyte D, Camacho-Hübner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM, Monson JP: Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 1998;83:3913-3919.
21. Rahim A, Holmes SJ, Adams JE, Shalet SM: Long-term change in the bone mineral density of adults with adult-onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy. Clin Endocrinol 1998;48:463-469.